Clinical Trials and Patient Registries for Cluster Headache
Researchers continue to find ways to treat cluster headache, a rare neurologic disorder that causes excruciating pain.
To enroll in a trial, visit clinicaltrials.gov and type “cluster headache” in the search field. In the meantime, here are two registries and one sample trial.
Cluster Headache Registry
What: The University of Texas Health Science Center in Houston is recruiting patients with cluster headaches for a national registry.
Where: The University of Texas Health Science Center, Houston, TX
When: Ongoing
For more information: Email Elena Viverette, RN, at ncct.wec@uth.tmc.edu or call 713-704-6900.
GammaCore Patient Registry
What: People with cluster headaches are asked to participate in a registry.
Where: Montefiore Medical Center, New York, NY
When: Ongoing
For more information: Email study coordinator Daniel Sun at dansun@montefiore.org or call 929-263-3831.
Evaluation of Fremanezumab as Preventive
What: Teva Pharmaceuticals USA seeks patients for a study of the efficacy and safety of fremanezumab—an anti-CGRP drug, FDA-approved for preventing migraine—for prevention of episodic cluster headache (ECH).
Where: Various locations
When: Ongoing
For more information: Email Teva U.S. Medical Information at USMedInfo@tevapharm.com or call 888-483-8279.
For more information on cluster headaches, read "Help for Horrid Headaches."
